LISA COOMBS: Open Payments
NPI 1184276438 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 9 payments from 7 companies in 2025. Trend: 2023 $234 · 2024 $306 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $137 |
| Vantive US Healthcare LLC | 1 | $29 |
| Veloxis Pharmaceuticals, Inc. | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Travere Therapeutics, Inc. | 2 | $14 |
Products named: JYNARQUE, Renal - PD, ENVARSUS, TARPEYO, Veltassa, LOKELMA.
Industry payments across MO — which companies pay providers there.
